360T Adrian MurdochAlex DavisAlex Davis Alison Tudor-AckroydAmerican Express Amy RotmanAndrew Tjaardstra Ann ShiBanco Santander Bank Negara Indonesia Bank of America Bank of China (Hong Kong) Baron LaudermilkBen HurleyBenny KungBernice CornforthBlack Swan BlackRock Bloomberg BNP Paribas Bottomline Technologies Broadridge Financial Solutions Cabot Corporation Carol HuangCathy AdamsCherie MarriottChris WrightChristopher ChuCiti Clipper Colin WaughCommercial Partner Content Lab Copper.co Co-Published ChapterCorporateTreasurer EditorsCT Staff Dan BlandDaniel FlattDanny LeungDBS E.SUN Elizabeth UtleyElla Arwyn JonesElla Arwyn Jones and Sara Velezmoro Emma BiFA ReportersFederated Hermes FinanceAsia EditorsFinLync Han Shih Toh Hang Seng Bank Honnus CheungHSBC HSBC Asset Management I-Ching NgiGTB Ingrid PiperJ.P. MorganJ.P. Morgan Jackie HorneJame DiBiasioJane CooperJill MaoJP Morgan Asset Management Kerry LiuKieron Pereira Kieron Pereira & Ella Arwyn Jones KVB Kunlun Kyriba Larissa Ku LendingStarLexisNexis Risk Solutions Liza TanMark AgnewMark Agnew xMarvin ZouMatthew KnightMatthew ThomasNick LordNishtha AsthanaOCBC Bank Partner ContentPeridot Peter ShadboltPhani KumarPhani Kumar Ravi BalakrishnanRay ChanRefinitiv RGE Richard MorrowRichard NewellRupert WalkerRyan Li Sam MacphersonSara VelezmoroSara Velezmoro and Ella Arwyn Jones Sara Velezmoro and Kieron Pereira Shruti ChaturvediSMBC Solomon TeagueStandard Chartered BankState Bank of India Steve DunthorneSuhas BhatSuhas Bhat Sustainable Fitch Techcombank The EditorsThomson Reuters TMF GroupTMF Group Tsering NamgyalUnited Overseas Bank (Malaysia) UOB Malaysia Vincent MorkriVisa Westpac
Former tax partner at KPMG China and now director of consultancy firm BC Advisory, Bolivia Cheung, offers a step-by-step guide for CFOs to take advantage of the Shanghai VAT pilot.
China's VAT tax pilot is now in full swing, with certain companies in Shanghai able to claim value-added tax rather than business tax when doing business. CT assesses the implications and consequences of this mammoth ...
A mysterious letter alleging fraudulent activity at China NT Pharma knocked the vaccine company's stock price off its perch. A sharp refutation from the firm's management has, however, calmed investors for now.
CT talks to Angelica Kwan (pictured), US tax partner at PwC's Hong Kong office, on why CFOs at financial institutions should get ready for Uncle Sam’s latest attempt to levy a new 30% withholding tax on US-related deals.